Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Complement system WP2806,2.720473648627786e-07,11.417525773195877,172.60204420299996,"['FCGR3A', 'CD93', 'PROS1', 'C5AR1', 'ITGAX', 'SPP1', 'F13A1', 'VSIG4', 'CD55', 'TLR2']",9.440043560738418e-05,0,0,10
2,"GPCRs, Class A Rhodopsin-like WP455",1.2509588140778185e-05,12.183150183150182,137.53576707061163,"['P2RY12', 'CX3CR1', 'P2RY13', 'CHRM3', 'CYSLTR1', 'HRH2', 'GPR65']",0.002170413542425015,0,0,7
3,Nuclear Receptors Meta-Pathway WP2882,0.000252662257103018,3.3379065040650406,27.64940470685024,"['STAT3', 'NRG1', 'SLC2A3', 'SLC6A6', 'SLC7A5', 'DNAJB1', 'BHLHE40', 'PDE4B', 'HMOX1', 'BAX', 'PLTP', 'FKBP5', 'CPEB4', 'HSPA1A']",0.029224601071582413,0,0,14
4,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.0014494423640614724,22.355704697986578,146.1297711312388,"['CDKN1A', 'SPP1', 'ENPP1']",0.12573912508233273,0,0,3
5,Monoamine GPCRs WP58,0.0018611225666117209,inf,inf,"['CHRM3', 'HRH2']",0.12916190612285344,0,0,2
6,Toll-like Receptor Signaling Pathway WP75,0.0028850926512139093,3.686564045413387,21.559757453210796,"['IFNAR2', 'SPP1', 'LY96', 'MAP3K8', 'TLR5', 'IKBKE', 'MAP2K6', 'TLR2']",0.14623384045228002,0,0,8
7,Complement and Coagulation Cascades WP558,0.0031946821059750034,8.14692378328742,46.81440493690595,"['PROS1', 'C5AR1', 'PLAT', 'CD55']",0.14623384045228002,0,0,4
8,Endochondral Ossification with Skeletal Dysplasias WP4808,0.003792808541989972,5.612331081081081,31.286773010210254,"['SCIN', 'SPP1', 'ENPP1', 'PLAT', 'IGF1']",0.14623384045228002,0,0,5
9,Endochondral Ossification WP474,0.003792808541989972,5.612331081081081,31.286773010210254,"['SCIN', 'SPP1', 'ENPP1', 'PLAT', 'IGF1']",0.14623384045228002,0,0,5
10,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.005423581822939585,44.575250836120404,232.54903140804035,"['CDKN1A', 'HIF1A']",0.17108935386909419,0,0,2
11,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.005423581822939585,44.575250836120404,232.54903140804035,"['STAT3', 'BAX']",0.17108935386909419,0,0,2
12,Regulation of toll-like receptor signaling pathway WP1449,0.006170339704363813,2.946396664681358,14.991270311091512,"['IFNAR2', 'IRAK2', 'SPP1', 'LY96', 'MAP3K8', 'TLR5', 'IKBKE', 'MAP2K6', 'TLR2']",0.1716565139659999,0,0,9
13,Lung fibrosis WP3624,0.006464886814049684,6.3982683982683985,32.25603691156626,"['CEBPB', 'SPP1', 'HMOX1', 'IGF1']",0.1716565139659999,0,0,4
14,Adipogenesis WP236,0.007325027443910212,3.425983436853002,16.843704969213807,"['CDKN1A', 'CEBPB', 'CEBPD', 'NAMPT', 'STAT3', 'IGF1', 'HIF1A']",0.1716565139659999,0,0,7
15,"GPCRs, Other WP117",0.007642458260355965,9.575263662511984,46.67017947244291,"['CHRM3', 'ADGRE2', 'P2RY13']",0.1716565139659999,0,0,3
16,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.007914997762121033,5.970819304152638,28.892769943686968,"['ANGPT2', 'BAX', 'SLC2A3', 'HIF1A']",0.1716565139659999,0,0,4
17,NRF2 pathway WP2884,0.008738333685327164,3.7451977401129946,17.752371221440985,"['SLC6A6', 'DNAJB1', 'HMOX1', 'SLC2A3', 'NRG1', 'HSPA1A']",0.17412495552395788,0,0,6
18,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.00963991981644006,2.3238399432171057,10.786898984180407,"['IFNAR2', 'GNG10', 'CDKN1A', 'IL4R', 'ANGPT2', 'DDIT4', 'ITGAX', 'SPP1', 'SLC2A3', 'IGF1', 'JAK3', 'HIF1A']",0.17412495552395788,0,0,12
19,Acute viral myocarditis WP4298,0.009796689693504926,3.643426477324782,16.853436974703452,"['STAT3', 'CASP1', 'BAX', 'TLR5', 'AIF1', 'CD55']",0.17412495552395788,0,0,6
20,Caloric restriction and aging WP4191,0.01053782151585912,22.28428093645485,101.45552760506321,"['NAMPT', 'IGF1']",0.17412495552395788,0,0,2
21,Inflammatory Response Pathway WP453,0.01053782151585912,22.28428093645485,101.45552760506321,"['IL4R', 'TNFRSF1B']",0.17412495552395788,0,0,2
22,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.011419746798881662,5.26678550207962,23.555230713598124,"['IFNAR2', 'OAS1', 'IKBKE', 'TLR2']",0.18012055178236078,0,0,4
23,Statin inhibition of cholesterol production WP430,0.013140236253433505,7.445190156599552,32.25313172494967,"['LIPC', 'APOC1', 'PLTP']",0.18998591583089278,0,0,3
24,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.013140236253433505,7.445190156599552,32.25313172494967,"['STAT3', 'SPP1', 'IGF1']",0.18998591583089278,0,0,3
25,Immune response to tuberculosis WP4197,0.02469598460156036,5.581375838926174,20.65731169094344,"['IFNAR2', 'OAS1', 'PTPN2']",0.30822575707184563,0,0,3
26,Transcriptional cascade regulating adipogenesis WP4211,0.024871242645566796,11.138795986622073,41.14719197517044,"['CEBPB', 'CEBPD']",0.30822575707184563,0,0,2
27,Macrophage markers WP4146,0.024871242645566796,11.138795986622073,41.14719197517044,"['CD163', 'CD83']",0.30822575707184563,0,0,2
28,Pyrimidine metabolism and related diseases WP4225,0.024871242645566796,11.138795986622073,41.14719197517044,"['DPYD', 'TYMP']",0.30822575707184563,0,0,2
29,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.02579867448782005,2.8639019112874142,10.47452696721907,"['WNT5A', 'STAT3', 'NRG1', 'IGF1', 'IKBKE', 'MAP2K6']",0.3086944843887433,0,0,6
30,Unfolded protein response WP4925,0.029445112169646216,5.1512648425400105,18.15937972613679,"['XBP1', 'HSPA5', 'TXNIP']",0.3169896097351193,0,0,3
31,Apoptosis WP254,0.03054808848715056,3.110454204204204,10.8506738141794,"['CASP4', 'CASP1', 'BAX', 'IGF1', 'TNFRSF1B']",0.3169896097351193,0,0,5
32,Oncostatin M Signaling Pathway WP2374,0.03349535655805565,3.0259313367421474,10.277117235506122,"['CEBPB', 'PXN', 'STAT3', 'JAK3', 'HIF1A']",0.3169896097351193,0,0,5
33,7-oxo-C and 7beta-HC pathways WP5064,0.03383750873811689,8.909698996655518,30.169892356194286,"['DBP', 'ACOT7']",0.3169896097351193,0,0,2
34,Biomarkers for pyrimidine metabolism disorders WP4584,0.03383750873811689,8.909698996655518,30.169892356194286,"['DPYD', 'TYMP']",0.3169896097351193,0,0,2
35,Differentiation of white and brown adipocyte WP2895,0.03383750873811689,8.909698996655518,30.169892356194286,"['PLAC8', 'CEBPB']",0.3169896097351193,0,0,2
36,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.03383750873811689,8.909698996655518,30.169892356194286,"['STAT3', 'HMOX1']",0.3169896097351193,0,0,2
37,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.03462109532987078,3.577104377104377,12.030846860518992,"['CDKN1A', 'CEBPB', 'CEBPD', 'SPP1']",0.3169896097351193,0,0,4
38,Apoptosis Modulation and Signaling WP1772,0.03990467860147329,2.86988911988912,9.244663915988644,"['CASP4', 'CASP1', 'BAX', 'TNFRSF1B', 'HSPA1A']",0.3169896097351193,0,0,5
39,MECP2 and Associated Rett Syndrome WP3584,0.03990467860147329,2.86988911988912,9.244663915988644,"['RBFOX1', 'CEBPD', 'BCL6', 'IGF1', 'FKBP5']",0.3169896097351193,0,0,5
40,Fatty acid beta-oxidation WP143,0.040274991523057385,4.4630872483221475,14.335545856799422,"['LIPC', 'GK', 'ACSL1']",0.3169896097351193,0,0,3
41,IL17 signaling pathway WP2112,0.040274991523057385,4.4630872483221475,14.335545856799422,"['CEBPB', 'CEBPD', 'STAT3']",0.3169896097351193,0,0,3
42,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.043209673176749654,inf,inf,['HRH2'],0.3169896097351193,0,0,1
43,"COVID-19, thrombosis and anticoagulation WP4927",0.043209673176749654,inf,inf,['F13A1'],0.3169896097351193,0,0,1
44,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.043848706822149065,7.423634336677815,23.21377918976252,"['CYSLTR1', 'LTC4S']",0.3169896097351193,0,0,2
45,Fluoropyrimidine Activity WP1601,0.043848706822149065,7.423634336677815,23.21377918976252,"['DPYD', 'TYMP']",0.3169896097351193,0,0,2
46,"NAD metabolism, sirtuins and aging WP3630",0.043848706822149065,7.423634336677815,23.21377918976252,"['NAMPT', 'HIF1A']",0.3169896097351193,0,0,2
47,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.043848706822149065,7.423634336677815,23.21377918976252,"['STAT3', 'JAK3']",0.3169896097351193,0,0,2
48,Overview of nanoparticle effects WP3287,0.043848706822149065,7.423634336677815,23.21377918976252,"['HMOX1', 'BAX']",0.3169896097351193,0,0,2
49,The influence of laminopathies on Wnt signaling WP4844,0.04634249905038851,4.183515100671141,12.850485901405746,"['CEBPB', 'CEBPD', 'SPP1']",0.3170502398845717,0,0,3
50,Spinal Cord Injury WP2431,0.04701084376408253,2.729070533948583,8.343797442297147,"['ZFP36', 'FCGR2A', 'TNFSF13', 'AIF1', 'TNFSF13B']",0.3170502398845717,0,0,5
51,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.05082781308329355,2.6636904761904763,7.935963861491818,"['HSPA5', 'PSMD5', 'CASP1', 'HSPA1B', 'HSPA1A']",0.3170502398845717,0,0,5
52,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.05220705700067548,3.0818530128874957,9.099286903300294,"['CDKN1A', 'HSPA5', 'NRG1', 'YBX3']",0.3170502398845717,0,0,4
53,Toll-like Receptor Signaling related to MyD88 WP3858,0.0528329392322874,3.9368337939202527,11.576733898429532,"['TLR5', 'IKBKE', 'TLR2']",0.3170502398845717,0,0,3
54,PI3K-Akt signaling pathway WP4172,0.05422113678489851,1.8742840778923253,5.462946692283406,"['IFNAR2', 'GNG10', 'CDKN1A', 'IL4R', 'ANGPT2', 'DDIT4', 'SPP1', 'IGF1', 'JAK3', 'TLR2']",0.3170502398845717,0,0,10
55,TP53 network WP1742,0.05479842096118657,6.362159579550884,18.476308825928818,"['CDKN1A', 'BAX']",0.3170502398845717,0,0,2
56,Triacylglyceride synthesis WP325,0.05479842096118657,6.362159579550884,18.476308825928818,"['LIPC', 'GK']",0.3170502398845717,0,0,2
57,Oxysterols derived from cholesterol WP4545,0.05479842096118657,6.362159579550884,18.476308825928818,"['DBP', 'ACOT7']",0.3170502398845717,0,0,2
58,Peptide GPCRs WP24,0.05479842096118657,6.362159579550884,18.476308825928818,"['CX3CR1', 'C5AR1']",0.3170502398845717,0,0,2
59,Phytochemical activity on NRF2 transcriptional activation WP3,0.05479842096118657,6.362159579550884,18.476308825928818,"['CEBPB', 'HMOX1']",0.3170502398845717,0,0,2
60,Vitamin D Receptor Pathway WP2877,0.05482136712701528,2.6013513513513513,7.553479535334623,"['CDKN1A', 'DUSP10', 'BCL6', 'SPP1', 'HIF1A']",0.3170502398845717,0,0,5
61,Notch Signaling Pathway Netpath WP61,0.057238117099313264,2.978675645342312,8.520606591491996,"['CDKN1A', 'STAT3', 'HIF1A', 'SAP30']",0.3256004366141263,0,0,4
62,TYROBP causal network in microglia WP3945,0.05899156643857848,2.541845823095823,7.194340744322101,"['DPYD', 'ITGAX', 'SPP1', 'TCIRG1', 'TNFRSF1B']",0.3290173924138171,0,0,5
63,Oxidative Damage WP3941,0.05973514617311377,3.7175615212527964,10.47547392345096,"['CDKN1A', 'C5AR1', 'TNFRSF1B']",0.3290173924138171,0,0,3
64,IL-4 signaling pathway WP395,0.06251964010926873,2.8821548821548824,7.990124570895445,"['CEBPB', 'IL4R', 'STAT3', 'JAK3']",0.33375869412178844,0,0,4
65,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.06251964010926873,2.8821548821548824,7.990124570895445,"['ANGPT2', 'PXN', 'STAT3', 'BAX']",0.33375869412178844,0,0,4
66,Cardiac Progenitor Differentiation WP2406,0.0665874283149368,5.566053511705686,15.079771940040018,"['NRG1', 'IGF1']",0.3371259077053389,0,0,2
67,Differentiation Pathway WP2848,0.0665874283149368,5.566053511705686,15.079771940040018,"['WNT5A', 'IGF1']",0.3371259077053389,0,0,2
68,Iron metabolism in placenta WP2007,0.0665874283149368,5.566053511705686,15.079771940040018,"['STEAP3', 'HAMP']",0.3371259077053389,0,0,2
69,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.06703656378002416,3.5213705404450724,9.516564031922695,"['IRAK2', 'LY96', 'PLAT']",0.3371259077053389,0,0,3
70,Gastric Cancer Network 2 WP2363,0.07912327957481698,4.946859903381642,12.548937668066108,"['PLAC8', 'RNF144B']",0.3714143726046279,0,0,2
71,Genes controlling nephrogenesis WP4823,0.07912327957481698,4.946859903381642,12.548937668066108,"['ROBO2', 'CXCL12']",0.3714143726046279,0,0,2
72,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.07912327957481698,4.946859903381642,12.548937668066108,"['IL4R', 'STAT3']",0.3714143726046279,0,0,2
73,Hepatitis C and Hepatocellular Carcinoma WP3646,0.08278107649361251,3.1850431447746885,7.935712683904053,"['CDKN1A', 'STAT3', 'HIF1A']",0.3714143726046279,0,0,3
74,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.08278107649361251,3.1850431447746885,7.935712683904053,"['CDKN1A', 'BAX', 'MAP2K6']",0.3714143726046279,0,0,3
75,PPAR signaling pathway WP3942,0.08278107649361251,3.1850431447746885,7.935712683904053,"['ACSL1', 'OLR1', 'PLTP']",0.3714143726046279,0,0,3
76,Blood Clotting Cascade WP272,0.08455831537684612,22.213333333333335,54.87390520660881,['PLAT'],0.3714143726046279,0,0,1
77,Thyroxine (Thyroid Hormone) Production WP1981,0.08455831537684612,22.213333333333335,54.87390520660881,['TG'],0.3714143726046279,0,0,1
78,Dopaminergic Neurogenesis WP2855,0.08455831537684612,22.213333333333335,54.87390520660881,['STAT3'],0.3714143726046279,0,0,1
79,Hfe effect on hepcidin production WP3924,0.08455831537684612,22.213333333333335,54.87390520660881,['HAMP'],0.3714143726046279,0,0,1
80,Purinergic signaling WP4900,0.09231990195013264,4.451505016722408,10.605690841008675,"['P2RY12', 'P2RY13']",0.40043757470870034,0,0,2
81,Cardiac Hypertrophic Response WP2795,0.09926819253127614,2.4125944125944128,5.572924395200877,"['NRG1', 'IGF1', 'IKBKE', 'MAP2K6']",0.4229406620293438,0,0,4
82,Amyotrophic lateral sclerosis (ALS) WP2447,0.09994563194929738,2.907207470090458,6.695673604726928,"['CASP1', 'BAX', 'MAP2K6']",0.4229406620293438,0,0,3
83,Hepatitis B infection WP4666,0.10208534692796982,1.8431372549019607,4.205939835526532,"['CDKN1A', 'STAT3', 'BAX', 'IKBKE', 'JAK3', 'MAP2K6', 'TLR2']",0.42316938652580116,0,0,7
84,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.10609722371107984,4.046214654910307,9.07727553081209,"['TLR5', 'TLR2']",0.42316938652580116,0,0,2
85,Transcription factor regulation in adipogenesis WP3599,0.10609722371107984,4.046214654910307,9.07727553081209,"['CEBPB', 'CEBPD']",0.42316938652580116,0,0,2
86,IL-9 signaling pathway WP22,0.10609722371107984,4.046214654910307,9.07727553081209,"['STAT3', 'JAK3']",0.42316938652580116,0,0,2
87,SARS coronavirus and innate immunity WP4912,0.10609722371107984,4.046214654910307,9.07727553081209,"['IFNAR2', 'IKBKE']",0.42316938652580116,0,0,2
88,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.10901958752202782,2.7856543624161074,6.173644390866065,"['IFNAR2', 'OAS1', 'IKBKE']",0.42988405534254154,0,0,3
89,Ferroptosis WP4313,0.11839859848735253,2.6738255033557046,5.705137181550454,"['STEAP3', 'ACSL1', 'HMOX1']",0.44403742486652215,0,0,3
90,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.1203808190676338,3.7084726867335562,7.851189238115646,"['FCGR2A', 'IKBKE']",0.44403742486652215,0,0,2
91,White fat cell differentiation WP4149,0.1203808190676338,3.7084726867335562,7.851189238115646,"['CEBPB', 'CEBPD']",0.44403742486652215,0,0,2
92,NRF2-ARE regulation WP4357,0.1203808190676338,3.7084726867335562,7.851189238115646,"['CEBPB', 'HMOX1']",0.44403742486652215,0,0,2
93,EV release from cardiac cells and their functional effects WP3297,0.12412573548141972,11.105,23.17014086864976,['CXCL12'],0.44403742486652215,0,0,1
94,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.12412573548141972,11.105,23.17014086864976,['CEBPB'],0.44403742486652215,0,0,1
95,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.12412573548141972,11.105,23.17014086864976,['HIF1A'],0.44403742486652215,0,0,1
96,miR-517 relationship with ARCN1 and USP1 WP3596,0.12412573548141972,11.105,23.17014086864976,['CDKN1A'],0.44403742486652215,0,0,1
97,Peroxiredoxin 2 induced ovarian failure WP4873,0.12412573548141972,11.105,23.17014086864976,['BAX'],0.44403742486652215,0,0,1
98,Glucocorticoid Receptor Pathway WP2880,0.12806523866297354,2.570598864223025,5.2831345473869336,"['BHLHE40', 'PDE4B', 'CPEB4']",0.4534554879188961,0,0,3
99,TNF-alpha signaling pathway WP231,0.1352074327966933,1.9242194780987885,3.850257614106367,"['BAX', 'MAP3K8', 'PYGL', 'TNFRSF1B', 'MAP2K6']",0.4670588548320549,0,0,5
100,DNA damage response (only ATM dependent) WP710,0.1352074327966933,1.9242194780987885,3.850257614106367,"['CDKN1A', 'MLKL', 'BCL6', 'WNT5A', 'BAX']",0.4670588548320549,0,0,5
101,Non-small cell lung cancer WP4255,0.13594508454765863,2.1237774571107906,4.238006973324834,"['CDKN1A', 'STAT3', 'BAX', 'JAK3']",0.4670588548320549,0,0,4
102,Bladder cancer WP2828,0.15019536070761016,3.177735308170091,6.024409155142691,"['CDKN1A', 'TYMP']",0.5011325977455839,0,0,2
103,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.15019536070761016,3.177735308170091,6.024409155142691,"['PTPN1', 'CEBPB']",0.5011325977455839,0,0,2
104,Photodynamic therapy-induced unfolded protein response WP3613,0.15019536070761016,3.177735308170091,6.024409155142691,"['XBP1', 'HSPA5']",0.5011325977455839,0,0,2
105,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.1619884068223547,7.402222222222222,13.473750724289408,['STAT3'],0.5107096714878291,0,0,1
106,Thiamine metabolic pathways WP4297,0.1619884068223547,7.402222222222222,13.473750724289408,['SLC25A19'],0.5107096714878291,0,0,1
107,Cysteine and methionine catabolism WP4504,0.1619884068223547,7.402222222222222,13.473750724289408,['SQOR'],0.5107096714878291,0,0,1
108,Farnesoid X receptor pathway WP2879,0.1619884068223547,7.402222222222222,13.473750724289408,['FKBP5'],0.5107096714878291,0,0,1
109,"GPCRs, Class B Secretin-like WP334",0.1619884068223547,7.402222222222222,13.473750724289408,['ADGRE2'],0.5107096714878291,0,0,1
110,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.1619884068223547,7.402222222222222,13.473750724289408,['LIPC'],0.5107096714878291,0,0,1
111,Neovascularisation processes WP4331,0.1656027536473267,2.9654403567447045,5.332346340667271,"['CXCL12', 'HIF1A']",0.5107096714878291,0,0,2
112,Chemokine signaling pathway WP3929,0.16688109766648032,1.6741525423728814,2.9975261139358023,"['CX3CR1', 'GNG10', 'CXCL12', 'PXN', 'STAT3', 'JAK3']",0.5107096714878291,0,0,6
113,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.16864595107892646,1.9379300248865465,3.4494257677409568,"['STAT3', 'BAX', 'NRG1', 'IGF1']",0.5107096714878291,0,0,4
114,G13 Signaling Pathway WP524,0.1692553666314131,2.226510067114094,3.9550537198002322,"['IQGAP1', 'IQGAP2', 'PFN1']",0.5107096714878291,0,0,3
115,Pyrimidine metabolism WP4022,0.1692553666314131,2.226510067114094,3.9550537198002322,"['DPYD', 'ENPP1', 'TYMP']",0.5107096714878291,0,0,3
116,Aryl Hydrocarbon Receptor Pathway WP2873,0.1812687298794866,2.7796822742474916,4.747070932243169,"['SLC7A5', 'BAX']",0.5290936935490989,0,0,2
117,IL-7 signaling pathway WP205,0.1812687298794866,2.7796822742474916,4.747070932243169,"['STAT3', 'JAK3']",0.5290936935490989,0,0,2
118,Endometrial cancer WP4155,0.1911185115501747,2.0867239932885906,3.4532393312385863,"['CDKN1A', 'BAX', 'CTNNA3']",0.5290936935490989,0,0,3
119,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.19179973847646622,1.6889332514332513,2.78894135567369,"['RYR2', 'SNAP25', 'CEBPB', 'BHLHE40', 'HIF1A']",0.5290936935490989,0,0,5
120,Signal transduction through IL1R WP4496,0.19714240895043839,2.6157780838087743,4.247576109497723,"['IRAK2', 'MAP2K6']",0.5290936935490989,0,0,2
121,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.1982195393699794,5.550833333333333,8.983358082068454,['CASP1'],0.5290936935490989,0,0,1
122,Cell Differentiation - Index WP2029,0.1982195393699794,5.550833333333333,8.983358082068454,['STAT3'],0.5290936935490989,0,0,1
123,Tryptophan catabolism leading to NAD+ production WP4210,0.1982195393699794,5.550833333333333,8.983358082068454,['NAMPT'],0.5290936935490989,0,0,1
124,Complement Activation WP545,0.1982195393699794,5.550833333333333,8.983358082068454,['CD55'],0.5290936935490989,0,0,1
125,GDNF/RET signaling axis WP4830,0.1982195393699794,5.550833333333333,8.983358082068454,['ROBO2'],0.5290936935490989,0,0,1
126,Hedgehog Signaling Pathway Netpath WP47,0.1982195393699794,5.550833333333333,8.983358082068454,['ARNTL'],0.5290936935490989,0,0,1
127,HIF1A and PPARG regulation of glycolysis WP2456,0.1982195393699794,5.550833333333333,8.983358082068454,['HIF1A'],0.5290936935490989,0,0,1
128,NAD+ metabolism WP3644,0.1982195393699794,5.550833333333333,8.983358082068454,['NAMPT'],0.5290936935490989,0,0,1
129,Nanomaterial-induced inflammasome activation WP3890,0.1982195393699794,5.550833333333333,8.983358082068454,['CASP1'],0.5290936935490989,0,0,1
130,NOTCH1 regulation of endothelial cell calcification WP3413,0.1982195393699794,5.550833333333333,8.983358082068454,['PLAT'],0.5290936935490989,0,0,1
131,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.20230667203202887,2.0231848688224527,3.2329898466321225,"['CDKN1A', 'PFN1', 'PFN2']",0.5318213272357123,0,0,3
132,Regulatory circuits of the STAT3 signaling pathway WP4538,0.20230667203202887,2.0231848688224527,3.2329898466321225,"['IFNAR2', 'STAT3', 'JAK3']",0.5318213272357123,0,0,3
133,Glycerophospholipid Biosynthetic Pathway WP2533,0.21317679832290146,2.47008547008547,3.8178466490906495,"['PGS1', 'GK']",0.5460307866363151,0,0,2
134,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.21364355262519322,1.9633833399131464,3.0303767409124167,"['IRAK2', 'MAP3K8', 'MAP2K6']",0.5460307866363151,0,0,3
135,Exercise-induced Circadian Regulation WP410,0.21364355262519322,1.9633833399131464,3.0303767409124167,"['CEBPB', 'ERC2', 'ARNTL']",0.5460307866363151,0,0,3
136,Senescence and Autophagy in Cancer WP615,0.22211507240423534,1.7127687127687128,2.5769627587987216,"['CDKN1A', 'CEBPB', 'PLAT', 'IGF1']",0.5460307866363151,0,0,4
137,Melatonin metabolism and effects WP3298,0.2293285541035735,2.339728920964619,3.445483801990134,"['PER3', 'ARNTL']",0.5460307866363151,0,0,2
138,Breast cancer pathway WP4262,0.2314360767082897,1.6801982085000953,2.458888706335326,"['CDKN1A', 'WNT5A', 'BAX', 'IGF1']",0.5460307866363151,0,0,4
139,Selective expression of chemokine receptors during T-cell polarization WP4494,0.23288921159128134,4.44,6.4699343680158625,['IL4R'],0.5460307866363151,0,0,1
140,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.23288921159128134,4.44,6.4699343680158625,['TLR2'],0.5460307866363151,0,0,1
141,Cytokines and Inflammatory Response WP530,0.23288921159128134,4.44,6.4699343680158625,['IL15'],0.5460307866363151,0,0,1
142,Fatty acid transporters WP5061,0.23288921159128134,4.44,6.4699343680158625,['ACSL1'],0.5460307866363151,0,0,1
143,FOXP3 in COVID-19 WP5063,0.23288921159128134,4.44,6.4699343680158625,['STAT3'],0.5460307866363151,0,0,1
144,Genes targeted by miRNAs in adipocytes WP1992,0.23288921159128134,4.44,6.4699343680158625,['IGF1'],0.5460307866363151,0,0,1
145,Kynurenine Pathway and links to Cellular Senescence WP5044,0.23288921159128134,4.44,6.4699343680158625,['CDKN1A'],0.5460307866363151,0,0,1
146,LDLRAD4 and what we know about it WP4904,0.23288921159128134,4.44,6.4699343680158625,['PMEPA1'],0.5460307866363151,0,0,1
147,Osteoclast Signaling WP12,0.23288921159128134,4.44,6.4699343680158625,['SPP1'],0.5460307866363151,0,0,1
148,Platelet-mediated interactions with vascular and circulating cells WP4462,0.23288921159128134,4.44,6.4699343680158625,['TLR2'],0.5460307866363151,0,0,1
149,3q29 copy number variation syndrome WP4906,0.23669852732414953,1.8537472035794182,2.671190371119801,"['PXN', 'HIF1A', 'HAMP']",0.5512375099428181,0,0,3
150,Type 2 papillary renal cell carcinoma WP4241,0.24555775515007675,2.222408026755853,3.120756698178838,"['CDKN1A', 'HIF1A']",0.5569185688697819,0,0,2
151,Hematopoietic Stem Cell Differentiation WP2849,0.24555775515007675,2.222408026755853,3.120756698178838,"['PIM1', 'RUNX1']",0.5569185688697819,0,0,2
152,Mitochondrial CIV Assembly WP4922,0.24555775515007675,2.222408026755853,3.120756698178838,"['PET100', 'COX14']",0.5569185688697819,0,0,2
153,Prion disease pathway WP3995,0.24555775515007675,2.222408026755853,3.120756698178838,"['HSPA5', 'STAT3']",0.5569185688697819,0,0,2
154,MET in type 1 papillary renal cell carcinoma WP4205,0.26015751852067964,1.7556517131755562,2.3639288350468926,"['CDKN1A', 'STAT3', 'JAK3']",0.5664072535189448,0,0,3
155,Integrated Cancer Pathway WP1971,0.2618276899429583,2.1162605510431596,2.8359344483717646,"['CDKN1A', 'BAX']",0.5664072535189448,0,0,2
156,Cell Differentiation - Index expanded WP2023,0.26606450237345247,3.6994444444444445,4.898125520313941,['STAT3'],0.5664072535189448,0,0,1
157,Development and heterogeneity of the ILC family WP3893,0.26606450237345247,3.6994444444444445,4.898125520313941,['IL15'],0.5664072535189448,0,0,1
158,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.26606450237345247,3.6994444444444445,4.898125520313941,['STAT3'],0.5664072535189448,0,0,1
159,Dual hijack model of Vif in HIV infection WP3300,0.26606450237345247,3.6994444444444445,4.898125520313941,['RUNX1'],0.5664072535189448,0,0,1
160,Estrogen Receptor Pathway WP2881,0.26606450237345247,3.6994444444444445,4.898125520313941,['STAT3'],0.5664072535189448,0,0,1
161,Galanin receptor pathway WP4970,0.26606450237345247,3.6994444444444445,4.898125520313941,['CDKN1A'],0.5664072535189448,0,0,1
162,Nanomaterial induced apoptosis WP2507,0.26606450237345247,3.6994444444444445,4.898125520313941,['BAX'],0.5664072535189448,0,0,1
163,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.26606450237345247,3.6994444444444445,4.898125520313941,['ANAPC11'],0.5664072535189448,0,0,1
164,Interferon type I signaling pathways WP585,0.2720010466414203,1.710376871450697,2.226824081263444,"['IFNAR2', 'STAT3', 'MAP2K6']",0.5755144096620295,0,0,3
165,Target Of Rapamycin (TOR) Signaling WP1471,0.2781046551791071,2.0197628458498023,2.5848072130147157,"['PRR5', 'DDIT4']",0.5805614476151312,0,0,2
166,IL-18 signaling pathway WP4754,0.28173632798641196,1.3442118226600985,1.702825562545534,"['CEBPB', 'NRN1', 'CD83', 'SPP1', 'TNFAIP2', 'HMOX1', 'BAX']",0.5805614476151312,0,0,7
167,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.29584529107709545,1.62645277459486,1.9808871294241084,"['NHSL1', 'TG', 'MGLL']",0.5805614476151312,0,0,3
168,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.29780961866136413,3.1704761904761907,3.8404005367340743,['STAT3'],0.5805614476151312,0,0,1
169,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.29780961866136413,3.1704761904761907,3.8404005367340743,['RYR2'],0.5805614476151312,0,0,1
170,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.29780961866136413,3.1704761904761907,3.8404005367340743,['RAB27A'],0.5805614476151312,0,0,1
171,Globo Sphingolipid Metabolism WP1424,0.29780961866136413,3.1704761904761907,3.8404005367340743,['ST6GALNAC5'],0.5805614476151312,0,0,1
172,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.29780961866136413,3.1704761904761907,3.8404005367340743,['ACSL1'],0.5805614476151312,0,0,1
173,NAD+ biosynthetic pathways WP3645,0.29780961866136413,3.1704761904761907,3.8404005367340743,['NAMPT'],0.5805614476151312,0,0,1
174,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.29780961866136413,3.1704761904761907,3.8404005367340743,['IGF1'],0.5805614476151312,0,0,1
175,Omega-3/Omega-6 FA synthesis WP4723,0.29780961866136413,3.1704761904761907,3.8404005367340743,['ACSL1'],0.5805614476151312,0,0,1
176,Ovarian infertility WP34,0.29780961866136413,3.1704761904761907,3.8404005367340743,['CEBPB'],0.5805614476151312,0,0,1
177,Proteoglycan biosynthesis WP4784,0.29780961866136413,3.1704761904761907,3.8404005367340743,['CHSY1'],0.5805614476151312,0,0,1
178,RalA downstream regulated genes WP2290,0.29780961866136413,3.1704761904761907,3.8404005367340743,['YBX3'],0.5805614476151312,0,0,1
179,ESC Pluripotency Pathways WP3931,0.30781912018015195,1.5874880153403643,1.870446547461512,"['WNT5A', 'STAT3', 'MAP2K6']",0.5967219815782834,0,0,3
180,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.3105587760464934,1.850891861761427,2.164399813450833,"['BST2', 'MAP2K6']",0.5986883071562956,0,0,2
181,Insulin Signaling WP481,0.31622806293857053,1.3218325222352745,1.52181468943414,"['SNAP25', 'PTPN1', 'XBP1', 'ENPP1', 'MAP3K8', 'MAP2K6']",0.5993713061028444,0,0,6
182,CAMKK2  Pathway WP4874,0.3266819094539561,1.7765886287625419,1.9875911030342606,"['CHRM3', 'HMOX1']",0.5993713061028444,0,0,2
183,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.3266819094539561,1.7765886287625419,1.9875911030342606,"['XBP1', 'HSPA5']",0.5993713061028444,0,0,2
184,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.328186017750837,2.77375,3.0904420853996304,['BAX'],0.5993713061028444,0,0,1
185,Leptin Insulin Overlap WP3935,0.328186017750837,2.77375,3.0904420853996304,['STAT3'],0.5993713061028444,0,0,1
186,LTF danger signal response pathway WP4478,0.328186017750837,2.77375,3.0904420853996304,['TLR2'],0.5993713061028444,0,0,1
187,miRNAs involved in DNA damage response WP1545,0.328186017750837,2.77375,3.0904420853996304,['CDKN1A'],0.5993713061028444,0,0,1
188,Omega-9 FA synthesis WP4724,0.328186017750837,2.77375,3.0904420853996304,['ACSL1'],0.5993713061028444,0,0,1
189,Osteopontin Signaling WP1434,0.328186017750837,2.77375,3.0904420853996304,['SPP1'],0.5993713061028444,0,0,1
190,PPAR-alpha pathway WP2878,0.328186017750837,2.77375,3.0904420853996304,['PLTP'],0.5993713061028444,0,0,1
191,Sleep regulation WP3591,0.35725252444732297,2.4651851851851854,2.5374456692126888,['PER3'],0.6070009095696158,0,0,1
192,Apoptosis Modulation by HSP70 WP384,0.35725252444732297,2.4651851851851854,2.5374456692126888,['HSPA1A'],0.6070009095696158,0,0,1
193,Autosomal recessive Osteopetrosis pathways WP4788,0.35725252444732297,2.4651851851851854,2.5374456692126888,['TCIRG1'],0.6070009095696158,0,0,1
194,Cancer immunotherapy by PD-1 blockade WP4585,0.35725252444732297,2.4651851851851854,2.5374456692126888,['STAT3'],0.6070009095696158,0,0,1
195,Vitamin B12 metabolism WP1533,0.35725252444732297,2.4651851851851854,2.5374456692126888,['PLAT'],0.6070009095696158,0,0,1
196,Wnt signaling in kidney disease WP4150,0.35725252444732297,2.4651851851851854,2.5374456692126888,['WNT5A'],0.6070009095696158,0,0,1
197,Development of ureteric collection system WP5053,0.35725252444732297,2.4651851851851854,2.5374456692126888,['ROBO2'],0.6070009095696158,0,0,1
198,Eicosanoid Synthesis WP167,0.35725252444732297,2.4651851851851854,2.5374456692126888,['LTC4S'],0.6070009095696158,0,0,1
199,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.35725252444732297,2.4651851851851854,2.5374456692126888,['WNT5A'],0.6070009095696158,0,0,1
200,IL1 and megakaryocytes in obesity WP2865,0.35725252444732297,2.4651851851851854,2.5374456692126888,['TLR2'],0.6070009095696158,0,0,1
201,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.35725252444732297,2.4651851851851854,2.5374456692126888,['MAP2K6'],0.6070009095696158,0,0,1
202,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.35725252444732297,2.4651851851851854,2.5374456692126888,['OAS1'],0.6070009095696158,0,0,1
203,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.35725252444732297,2.4651851851851854,2.5374456692126888,['HMOX1'],0.6070009095696158,0,0,1
204,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.35725252444732297,2.4651851851851854,2.5374456692126888,['SLC2A3'],0.6070009095696158,0,0,1
205,Signaling of Hepatocyte Growth Factor Receptor WP313,0.35860284282931193,1.6444939923200792,1.686494023975938,"['PXN', 'STAT3']",0.6070009095696158,0,0,2
206,TGF-beta Receptor Signaling WP560,0.37436004916164,1.5855231724796943,1.5578355719460244,"['STAT3', 'SPP1']",0.6213714694611056,0,0,2
207,Genotoxicity pathway WP4286,0.37436004916164,1.5855231724796943,1.5578355719460244,"['CDKN1A', 'CEBPD']",0.6213714694611056,0,0,2
208,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.37436004916164,1.5855231724796943,1.5578355719460244,"['IFNAR2', 'CXCL12']",0.6213714694611056,0,0,2
209,Hippo-Merlin Signaling Dysregulation WP4541,0.37961859440169093,1.3877936241610738,1.344200568987434,"['ITGAX', 'CDH12', 'CDH18']",0.6213714694611056,0,0,3
210,Angiogenesis WP1539,0.3850654436945848,2.2183333333333333,2.1170486156899506,['HIF1A'],0.6213714694611056,0,0,1
211,Type II diabetes mellitus WP1584,0.3850654436945848,2.2183333333333333,2.1170486156899506,['GK'],0.6213714694611056,0,0,1
212,Imatinib and Chronic Myeloid Leukemia WP3640,0.3850654436945848,2.2183333333333333,2.1170486156899506,['PIM1'],0.6213714694611056,0,0,1
213,Pre-implantation embryo WP3527,0.3850654436945848,2.2183333333333333,2.1170486156899506,['ZFP36'],0.6213714694611056,0,0,1
214,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.38995791610311015,1.5306193057317494,1.4414093836535464,"['RYR2', 'CTNNA3']",0.6213714694611056,0,0,2
215,Cytosolic DNA-sensing pathway WP4655,0.38995791610311015,1.5306193057317494,1.4414093836535464,"['CASP1', 'IKBKE']",0.6213714694611056,0,0,2
216,IL-2 signaling pathway WP49,0.38995791610311015,1.5306193057317494,1.4414093836535464,"['STAT3', 'JAK3']",0.6213714694611056,0,0,2
217,p53 transcriptional gene network WP4963,0.38995791610311015,1.5306193057317494,1.4414093836535464,"['CDKN1A', 'BAX']",0.6213714694611056,0,0,2
218,Prolactin Signaling Pathway WP2037,0.39147612178628105,1.3592658539926037,1.2747613248376042,"['PTPN1', 'PXN', 'STAT3']",0.6213714694611056,0,0,3
219,Circadian rhythm related genes WP3594,0.3921623971526862,1.2340465465465464,1.1551653614749415,"['PER3', 'DBP', 'NAMPT', 'BHLHE40', 'ARNTL']",0.6213714694611056,0,0,5
220,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.41167866791772467,2.0163636363636366,1.7895472587086696,['MAP2K6'],0.6293061575658611,0,0,1
221,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.41167866791772467,2.0163636363636366,1.7895472587086696,['P4HA1'],0.6293061575658611,0,0,1
222,Fatty Acid Biosynthesis WP357,0.41167866791772467,2.0163636363636366,1.7895472587086696,['ACSL1'],0.6293061575658611,0,0,1
223,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.41167866791772467,2.0163636363636366,1.7895472587086696,['CDKN1A'],0.6293061575658611,0,0,1
224,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.41167866791772467,2.0163636363636366,1.7895472587086696,['HIF1A'],0.6293061575658611,0,0,1
225,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.41167866791772467,2.0163636363636366,1.7895472587086696,['PXN'],0.6293061575658611,0,0,1
226,Monoamine Transport WP727,0.41167866791772467,2.0163636363636366,1.7895472587086696,['NECTIN2'],0.6293061575658611,0,0,1
227,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.41167866791772467,2.0163636363636366,1.7895472587086696,['BAX'],0.6293061575658611,0,0,1
228,Allograft Rejection WP2328,0.42061469312007016,1.431438127090301,1.2396799309598425,"['CXCL12', 'CD55']",0.6318324610937851,0,0,2
229,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.42061469312007016,1.431438127090301,1.2396799309598425,"['STAT3', 'SPP1']",0.6318324610937851,0,0,2
230,DNA damage response WP707,0.42061469312007016,1.431438127090301,1.2396799309598425,"['CDKN1A', 'BAX']",0.6318324610937851,0,0,2
231,miRNA regulation of DNA damage response WP1530,0.42061469312007016,1.431438127090301,1.2396799309598425,"['CDKN1A', 'BAX']",0.6318324610937851,0,0,2
232,Leptin signaling pathway WP2034,0.4266712826336828,1.2802658750645328,1.0904554387142822,"['PTPN1', 'STAT3', 'BAX']",0.6336363600745875,0,0,3
233,Pancreatic adenocarcinoma pathway WP4263,0.4266712826336828,1.2802658750645328,1.0904554387142822,"['CDKN1A', 'STAT3', 'BAX']",0.6336363600745875,0,0,3
234,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.4356471219790388,1.3864966555183946,1.1520715675537356,"['CXCL12', 'IKBKE']",0.6336363600745875,0,0,2
235,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.43714378010687316,1.8480555555555556,1.5292532608112934,['BCL6'],0.6336363600745875,0,0,1
236,Folate Metabolism WP176,0.43714378010687316,1.8480555555555556,1.5292532608112934,['PLAT'],0.6336363600745875,0,0,1
237,Heart Development WP1591,0.43714378010687316,1.8480555555555556,1.5292532608112934,['BHLHE40'],0.6336363600745875,0,0,1
238,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.43714378010687316,1.8480555555555556,1.5292532608112934,['NAMPT'],0.6336363600745875,0,0,1
239,Ebola Virus Pathway on Host WP4217,0.437347066898805,1.1995631995631995,0.9920725885262215,"['BST2', 'SCIN', 'IQGAP1', 'IKBKE']",0.6336363600745875,0,0,4
240,Integrin-mediated Cell Adhesion WP185,0.43824993204006046,1.2559199696087122,1.0360911609318821,"['PXN', 'ITGAX', 'MAP2K6']",0.6336363600745875,0,0,3
241,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.461133452064482,1.2098840756558877,0.9365322974471102,"['WNT5A', 'HIF1A', 'MAP2K6']",0.656327962721854,0,0,3
242,Cell migration and invasion through p75NTR WP4561,0.46151015246147653,1.7056410256410257,1.3188890149571166,['STAT3'],0.656327962721854,0,0,1
243,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.46151015246147653,1.7056410256410257,1.3188890149571166,['ANGPT2'],0.656327962721854,0,0,1
244,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.46151015246147653,1.7056410256410257,1.3188890149571166,['RAB27A'],0.656327962721854,0,0,1
245,miRNA regulation of p53 pathway in prostate cancer WP3982,0.4848250409087327,1.5835714285714286,1.1464537628836704,['BAX'],0.6811104825721872,0,0,1
246,Overview of interferons-mediated signaling pathway WP4558,0.4848250409087327,1.5835714285714286,1.1464537628836704,['IFNAR2'],0.6811104825721872,0,0,1
247,SARS-CoV-2 mitochondrial interactions WP5038,0.4848250409087327,1.5835714285714286,1.1464537628836704,['IKBKE'],0.6811104825721872,0,0,1
248,Retinoblastoma gene in cancer WP2446,0.49356042582170323,1.231698253437384,0.8697144342694987,"['CDKN1A', 'SAP30']",0.68129137852319,0,0,2
249,MAPK Signaling Pathway WP382,0.49431309836901555,1.0728813559322035,0.755937354921805,"['DUSP10', 'MAP3K8', 'HSPA1B', 'HSPA1A', 'RASGRP3', 'MAP2K6']",0.68129137852319,0,0,6
250,Androgen receptor signaling pathway WP138,0.49467889545343896,1.146783152048137,0.8071592194815111,"['CDKN1A', 'LIMK2', 'STAT3']",0.68129137852319,0,0,3
251,Cytoplasmic Ribosomal Proteins WP477,0.49477068411482383,1.1085858585858586,0.7800685098630716,"['RPS15A', 'RPL38', 'RPL23A', 'RPL39']",0.68129137852319,0,0,4
252,Regulation of Actin Cytoskeleton WP51,0.49477068411482383,1.1085858585858586,0.7800685098630716,"['CHRM3', 'PXN', 'IQGAP1', 'PFN1']",0.68129137852319,0,0,4
253,Vitamin D in inflammatory diseases WP4482,0.5071336753942007,1.4777777777777779,1.0033825169806199,['MAP2K6'],0.6824936493376164,0,0,1
254,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.5071336753942007,1.4777777777777779,1.0033825169806199,['WNT5A'],0.6824936493376164,0,0,1
255,Oxidative Stress WP408,0.5071336753942007,1.4777777777777779,1.0033825169806199,['HMOX1'],0.6824936493376164,0,0,1
256,Small cell lung cancer WP4658,0.5074448459052018,1.1982283286631112,0.8128388585734253,"['CDKN1A', 'BAX']",0.6824936493376164,0,0,2
257,Synaptic Vesicle Pathway WP2267,0.5074448459052018,1.1982283286631112,0.8128388585734253,"['SNAP25', 'SYN3']",0.6824936493376164,0,0,2
258,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.5074448459052018,1.1982283286631112,0.8128388585734253,"['PIM1', 'MAP2K6']",0.6824936493376164,0,0,2
259,Physiological and pathological hypertrophy of the heart WP1528,0.528479346494954,1.3852083333333334,0.8834187670796371,['STAT3'],0.7080398966554017,0,0,1
260,Melanoma WP4685,0.5344601709055916,1.136437698310608,0.7119760222128169,"['CDKN1A', 'BAX']",0.7132987665547703,0,0,2
261,Gastrin signaling pathway WP4659,0.5377269544853699,1.0721476510067114,0.6651650849634002,"['CDKN1A', 'PXN', 'STAT3']",0.7133689530872059,0,0,3
262,AGE/RAGE pathway WP2324,0.5475831194466898,1.1078595317725752,0.6671984460930555,"['STAT3', 'HIF1A']",0.7133689530872059,0,0,2
263,IL-1 signaling pathway WP195,0.5475831194466898,1.1078595317725752,0.6671984460930555,"['IRAK2', 'MAP2K6']",0.7133689530872059,0,0,2
264,Pathogenic Escherichia coli infection WP2272,0.5475831194466898,1.1078595317725752,0.6671984460930555,"['LY96', 'TLR5']",0.7133689530872059,0,0,2
265,TLR4 Signaling and Tolerance WP3851,0.5489034883985129,1.3035294117647058,0.781899499056588,['IKBKE'],0.7133689530872059,0,0,1
266,EPO Receptor Signaling WP581,0.5489034883985129,1.3035294117647058,0.781899499056588,['STAT3'],0.7133689530872059,0,0,1
267,Nanoparticle-mediated activation of receptor signaling WP2643,0.5489034883985129,1.3035294117647058,0.781899499056588,['PXN'],0.7133689530872059,0,0,1
268,Type II interferon signaling (IFNG) WP619,0.5684457580776322,1.230925925925926,0.6952877494038161,['OAS1'],0.7332738961075776,0,0,1
269,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5684457580776322,1.230925925925926,0.6952877494038161,['BAX'],0.7332738961075776,0,0,1
270,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5853817445118032,1.0301003344481605,0.5516095507490114,"['CDKN1A', 'BAX']",0.7518044526951863,0,0,2
271,ATM Signaling Pathway WP2516,0.5871441114708803,1.1659649122807016,0.620858807921937,['CDKN1A'],0.7518044526951863,0,0,1
272,Head and Neck Squamous Cell Carcinoma WP4674,0.5974531638655104,1.00653694131955,0.5184464288000552,"['CDKN1A', 'DDIT4']",0.7621920877254856,0,0,2
273,16p11.2 proximal deletion syndrome WP4949,0.6208015229550284,0.9624836411225826,0.4588581632743378,"['MVP', 'MAP2K6']",0.779375555198797,0,0,2
274,Pathways in clear cell renal cell carcinoma WP4018,0.6208015229550284,0.9624836411225826,0.4588581632743378,"['STAT3', 'HIF1A']",0.779375555198797,0,0,2
275,Pathways Regulating Hippo Signaling WP4540,0.6208015229550284,0.9624836411225826,0.4588581632743378,"['CDH12', 'CDH18']",0.779375555198797,0,0,2
276,miRNA regulation of prostate cancer signaling pathways WP3981,0.6221528207206535,1.0546031746031745,0.5004825265207077,['CDKN1A'],0.779375555198797,0,0,1
277,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6221528207206535,1.0546031746031745,0.5004825265207077,['CASP1'],0.779375555198797,0,0,1
278,B Cell Receptor Signaling Pathway WP23,0.6264235525305364,0.9349654976840911,0.4373100426823044,"['BCL6', 'RASGRP3', 'MAP2K6']",0.7819027795974681,0,0,3
279,Aryl Hydrocarbon Receptor Netpath WP2586,0.6385312219230754,1.0065151515151516,0.4515073031694917,['CDKN1A'],0.7882224620226055,0,0,1
280,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6430947558498299,0.9221014492753623,0.4070738568545395,"['STAT3', 'MAP2K6']",0.7882224620226055,0,0,2
281,Glioblastoma signaling pathways WP2261,0.6430947558498299,0.9221014492753623,0.4070738568545395,"['CDKN1A', 'MAP2K6']",0.7882224620226055,0,0,2
282,Disruption of postsynaptic signaling by CNV WP4875,0.6542019281340357,0.9626086956521739,0.40847261977298677,['RYR2'],0.7882224620226055,0,0,1
283,Glycogen Synthesis and Degradation WP500,0.6542019281340357,0.9626086956521739,0.40847261977298677,['PYGL'],0.7882224620226055,0,0,1
284,MAPK Cascade WP422,0.6542019281340357,0.9626086956521739,0.40847261977298677,['MAP2K6'],0.7882224620226055,0,0,1
285,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.6542019281340357,0.9626086956521739,0.40847261977298677,['STAT3'],0.7882224620226055,0,0,1
286,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.6542019281340357,0.9626086956521739,0.40847261977298677,['WNT5A'],0.7882224620226055,0,0,1
287,Neural Crest Cell Migration during Development WP4564,0.6542019281340357,0.9626086956521739,0.40847261977298677,['STAT3'],0.7882224620226055,0,0,1
288,PDGFR-beta pathway WP3972,0.6542019281340357,0.9626086956521739,0.40847261977298677,['STAT3'],0.7882224620226055,0,0,1
289,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6691954206396014,0.9223611111111111,0.37049322980662847,['IGF1'],0.7925283650578214,0,0,1
290,G1 to S cell cycle control WP45,0.6691954206396014,0.9223611111111111,0.37049322980662847,['CDKN1A'],0.7925283650578214,0,0,1
291,Glycolysis and Gluconeogenesis WP534,0.6691954206396014,0.9223611111111111,0.37049322980662847,['SLC2A3'],0.7925283650578214,0,0,1
292,NO/cGMP/PKG mediated Neuroprotection WP4008,0.6691954206396014,0.9223611111111111,0.37049322980662847,['TSPO'],0.7925283650578214,0,0,1
293,p38 MAPK Signaling Pathway WP400,0.6691954206396014,0.9223611111111111,0.37049322980662847,['MAP2K6'],0.7925283650578214,0,0,1
294,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.6835408719424345,0.8853333333333333,0.33684173447625854,['ACSL1'],0.8025139156379137,0,0,1
295,Phosphodiesterases in neuronal function WP4222,0.6835408719424345,0.8853333333333333,0.33684173447625854,['PDE4B'],0.8025139156379137,0,0,1
296,Thermogenesis WP4321,0.6845651845211022,0.8506560329302805,0.32237431570768205,"['ACSL1', 'MGLL']",0.8025139156379137,0,0,2
297,Cell cycle WP179,0.6942970199798715,0.8344797122483751,0.3044644520305128,"['CDKN1A', 'ANAPC11']",0.8092019133215413,0,0,2
298,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.6972662019687057,0.8511538461538461,0.30691587651399116,['STAT3'],0.8092019133215413,0,0,1
299,Neural Crest Cell Migration in Cancer WP4565,0.6972662019687057,0.8511538461538461,0.30691587651399116,['STAT3'],0.8092019133215413,0,0,1
300,TGF-beta Signaling Pathway WP366,0.7104518660277458,0.818294804871986,0.27973741798134005,"['CDKN1A', 'LIMK2', 'MAP2K6']",0.821755991705426,0,0,3
301,T-cell receptor (TCR) signaling pathway WP69,0.7130180670217383,0.8038917604134995,0.27191519775587136,"['CD83', 'MAP3K8']",0.8219842832443295,0,0,2
302,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.7180009518269428,0.8081928302504502,0.26774166414137396,"['PTPN1', 'MAP3K8', 'MAP2K6']",0.8225176894040279,0,0,3
303,Copper homeostasis WP3286,0.7229622342023876,0.7901190476190476,0.2563132703453215,['STEAP3'],0.8225176894040279,0,0,1
304,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7229622342023876,0.7901190476190476,0.2563132703453215,['BAX'],0.8225176894040279,0,0,1
305,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.7229622342023876,0.7901190476190476,0.2563132703453215,['WNT5A'],0.8225176894040279,0,0,1
306,ErbB signaling pathway WP673,0.7307714259201851,0.7754503315144048,0.24322352863153868,"['CDKN1A', 'NRG1']",0.8227067596288897,0,0,2
307,G Protein Signaling Pathways WP35,0.7307714259201851,0.7754503315144048,0.24322352863153868,"['GNG10', 'PDE4B']",0.8227067596288897,0,0,2
308,Interleukin-11 Signaling Pathway WP2332,0.7349829841065009,0.7627586206896552,0.2348594286824492,['STAT3'],0.8227067596288897,0,0,1
309,Microglia Pathogen Phagocytosis Pathway WP3937,0.7349829841065009,0.7627586206896552,0.2348594286824492,['FCER1G'],0.8227067596288897,0,0,1
310,PDGF Pathway WP2526,0.7349829841065009,0.7627586206896552,0.2348594286824492,['STAT3'],0.8227067596288897,0,0,1
311,Selenium Micronutrient Network WP15,0.746483804509006,0.7372222222222222,0.2155500340908602,['PLAT'],0.8261542864857833,0,0,1
312,IL-6 signaling pathway WP364,0.746483804509006,0.7372222222222222,0.2155500340908602,['STAT3'],0.8261542864857833,0,0,1
313,7q11.23 copy number variation syndrome WP4932,0.7475862995865589,0.7489371350830452,0.21786995379061558,"['SNAP25', 'NRG1']",0.8261542864857833,0,0,2
314,Mesodermal commitment pathway WP2857,0.7475862995865589,0.7489371350830452,0.21786995379061558,"['BHLHE40', 'RPL38']",0.8261542864857833,0,0,2
315,IL-5 signaling pathway WP127,0.7574871119885282,0.7133333333333334,0.198127445675515,['STAT3'],0.834438183682601,0,0,1
316,Focal Adhesion WP306,0.7601238724386086,0.7524023794996949,0.20636431161932126,"['PXN', 'SPP1', 'IGF1']",0.8346929865069531,0,0,3
317,Splicing factor NOVA regulated synaptic proteins WP4148,0.7680143596246803,0.6909375,0.18237077569163535,['EPB41L3'],0.8361912159118818,0,0,1
318,Regulation of Microtubule Cytoskeleton WP2038,0.7680143596246803,0.6909375,0.18237077569163535,['STAT3'],0.8361912159118818,0,0,1
319,EGF/EGFR signaling pathway WP437,0.7687175731293668,0.7603622431208638,0.1999993293580111,"['PLSCR1', 'LIMK2', 'STAT3', 'IQGAP1']",0.8361912159118818,0,0,4
320,RANKL/RANK signaling pathway WP2018,0.7780860785849206,0.6698989898989899,0.16808979518180406,['MAP2K6'],0.8437370914655233,0,0,1
321,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.7877219173618338,0.6500980392156863,0.15511998945312203,['CDKN1A'],0.8498445135994225,0,0,1
322,AMP-activated protein kinase (AMPK) signaling WP1403,0.7969406795123423,0.6314285714285715,0.1433185206369656,['CDKN1A'],0.8498445135994225,0,0,1
323,Modulators of TCR signaling and T cell activation WP5072,0.7969406795123423,0.6314285714285715,0.1433185206369656,['MAP3K8'],0.8498445135994225,0,0,1
324,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7969406795123423,0.6314285714285715,0.1433185206369656,['TLR2'],0.8498445135994225,0,0,1
325,Ectoderm Differentiation WP2858,0.7995099427140775,0.6687949731427992,0.14964709575180626,"['PLCXD3', 'PIM1']",0.8498445135994225,0,0,2
326,22q11.2 copy number variation syndrome WP4657,0.8057603601562248,0.6137962962962963,0.13256091129687267,['ARNTL'],0.8498445135994225,0,0,1
327,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.8057603601562248,0.6137962962962963,0.13256091129687267,['MAP3K8'],0.8498445135994225,0,0,1
328,Mitochondrial complex I assembly model OXPHOS system WP4324,0.8057603601562248,0.6137962962962963,0.13256091129687267,['NDUFB3'],0.8498445135994225,0,0,1
329,Rett syndrome causing genes WP4312,0.8057603601562248,0.6137962962962963,0.13256091129687267,['CECR2'],0.8498445135994225,0,0,1
330,DNA IR-damage and cellular response via ATR WP4016,0.8222706208972648,0.5813157894736842,0.11375519625566581,['BCL6'],0.8620178412427519,0,0,1
331,IL-3 signaling pathway WP286,0.8222706208972648,0.5813157894736842,0.11375519625566581,['STAT3'],0.8620178412427519,0,0,1
332,Osteoblast differentiation WP4787,0.8373817689969288,0.5520833333333334,0.09798109812042054,['WNT5A'],0.8752152826564286,0,0,1
333,VEGFA-VEGFR2 Signaling Pathway WP3888,0.851087560173875,0.7385716484531322,0.1190874881559892,"['PTPN1', 'STAT3', 'PXN', 'TXNIP', 'IQGAP1', 'PFN1', 'TMSB10', 'MAP2K6', 'HSPA1A']",0.885562119534986,0,0,9
334,Nonalcoholic fatty liver disease WP4396,0.852385440705145,0.6289549376797698,0.10045445567957893,"['XBP1', 'NDUFB3', 'BAX']",0.885562119534986,0,0,3
335,Kit receptor signaling pathway WP304,0.857680975671333,0.5133333333333333,0.07880851022375378,['STAT3'],0.8884038762923956,0,0,1
336,Wnt signaling pathway and pluripotency WP399,0.8638695787111059,0.5015909090909091,0.073399539320186,['WNT5A'],0.8895036908390318,0,0,1
337,Male infertility WP4673,0.8638695787111059,0.5015909090909091,0.073399539320186,['ARNTL'],0.8895036908390318,0,0,1
338,Proteasome Degradation WP183,0.8697899275877654,0.49037037037037035,0.06840841191103599,['PSMD5'],0.8908574890062786,0,0,1
339,Calcium Regulation in the Cardiac Cell WP536,0.8713850619763406,0.5576393886795648,0.07677094403303217,"['CHRM3', 'RYR2']",0.8908574890062786,0,0,2
340,Alzheimer's disease WP2059,0.8754536131156802,0.4796376811594203,0.06379810058707487,['ATP5MD'],0.8908574890062786,0,0,1
341,Wnt signaling WP428,0.8754536131156802,0.4796376811594203,0.06379810058707487,['WNT5A'],0.8908574890062786,0,0,1
342,Myometrial relaxation and contraction pathways WP289,0.8842071993746586,0.5369932294640672,0.06608445712881776,"['RYR2', 'PDE4B']",0.8971342052134694,0,0,2
343,Integrated breast cancer pathway WP1984,0.8958403840319024,0.517804446193193,0.05695487723889381,"['BAX', 'RASGRP3']",0.9062875022130323,0,0,2
344,Ras signaling WP4223,0.9298220802520787,0.45770624303233,0.03330363204276352,"['GNG10', 'RASGRP3']",0.9379309937426491,0,0,2
345,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9393526609080822,0.4391304347826087,0.027473888067991174,"['STAT3', 'SPP1']",0.944798183580013,0,0,2
346,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9700908797244742,0.2814957264957265,0.008547764516986798,['NDUFB3'],0.9728946105907298,0,0,1
347,Ciliary landscape WP4352,0.9844098212574555,0.32111941766673224,0.005045744149204846,"['IQGAP1', 'IQGAP2']",0.9844098212574555,0,0,2
